secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001104659-24-032964
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS regains Nasdaq minimum bid price compliance effective March 11, 2024
---------------------------------------------------------------------------

- Nasdaq confirmed compliance after closing bid price above $1.00 for 10 consecutive business days through March 8, 2024.
- Company had been notified of non-compliance on February 14, 2024, and given a 180-day grace period until August 12, 2024.
- Non-compliance matter is now closed; no further action required.
- This removes a potential delisting risk for SELLAS common stock (SLS).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924032964/0001104659-24-032964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924032964/tm248504d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-032964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer